Accipiter Biosciences Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 22

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $10.5M

  • Investors
  • 12

Accipiter Biosciences General Information

Description

Developer of a biotechnology platform designed to engineer biologic therapies for the treatment of complex diseases. The company offers computationally designed multifunctional proteins that combine multiple therapeutic mechanisms within a single molecule, enabling healthcare and pharmaceutical companies to develop treatments with improved safety, effectiveness, and patient convenience.

Contact Information

Website
www.accipiterbio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1616 Eastlake Avenue East
  • Suite 208
  • Seattle, WA 98102
  • United States
+1 (973)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Other Healthcare Services
Vertical(s)
Artificial Intelligence & Machine Learning, Life Sciences
Corporate Office
  • 1616 Eastlake Avenue East
  • Suite 208
  • Seattle, WA 98102
  • United States
+1 (973)

Accipiter Biosciences Timeline

202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Accipiter Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Seed Round 21-Jul-2026 $10.5M Completed Pre-Clinical Trials
3. Seed Round 17-May-2024 Completed Pre-Clinical Trials
2. Accelerator/Incubator 02-May-2024 $840K Completed Stealth
1. Seed Round 19-Apr-2023 $840K $840K Completed Stealth
To view Accipiter Biosciences’s complete valuation and funding history, request access »

Accipiter Biosciences Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed 2
Seed 1
Seed 17,698,005 $0.000100 7% $0.72 $0.72 1x $0.72 36.78%
To view Accipiter Biosciences’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Accipiter Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Accipiter Biosciences Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Washington Research Foundation Limited Partner Minority
Alexandria Venture Investments Venture Capital Minority
Cercano Management PE/Buyout Minority
Columbus Venture Partners Venture Capital Minority
Flying Fish Partners Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

Ready to get started?

Request a free trial

Accipiter Biosciences FAQs

  • When was Accipiter Biosciences founded?

    Accipiter Biosciences was founded in 2023.

  • Where is Accipiter Biosciences headquartered?

    Accipiter Biosciences is headquartered in Seattle, WA.

  • What is the size of Accipiter Biosciences?

    Accipiter Biosciences has 22 total employees.

  • What industry is Accipiter Biosciences in?

    Accipiter Biosciences’s primary industry is Biotechnology.

  • Is Accipiter Biosciences a private or public company?

    Accipiter Biosciences is a Private company.

  • What is the current valuation of Accipiter Biosciences?

    The current valuation of Accipiter Biosciences is .

  • What is Accipiter Biosciences’s current revenue?

    The current revenue for Accipiter Biosciences is .

  • How much funding has Accipiter Biosciences raised over time?

    Accipiter Biosciences has raised $24.1M.

  • Who are Accipiter Biosciences’s investors?

    Washington Research Foundation, Alexandria Venture Investments, Cercano Management, Columbus Venture Partners, and Flying Fish Partners are 5 of 12 investors who have invested in Accipiter Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process